ESC Premium Access

Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation

Event: ESC CONGRESS 2019
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by The Bristol-Myers Squibb/Pfizer Alliance
Date: 1 September 2019
Time: 18:15 - 19:45

Congress Session

7 presentations in this session

Welcome and objectives

Speaker: Professor G. Montalescot (Paris, FR)
Thumbnail

Anticoagulation in atrial fibrillation - Current landscape

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

Establishing NOACs as standard of care in clinical practice

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Exploring outstanding unmet needs in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention

Speaker: Professor R. Lopes (Durham, US)
Thumbnail

Advancing patient care with NOACs in other cardiac interventions

Speaker: Professor G. Montalescot (Paris, FR)
Thumbnail

Improving outcomes through atrial fibrillation screening - Future directions

Speaker: Professor R. Schnabel (Hamburg, DE)
Thumbnail

Debate: Applying learnings to improve clinical practice

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

7 speakers from this session

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
3 followers

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20 presentations
0 follower

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Professor Renate B Schnabel

University Heart & Vascular Center Hamburg, Hamburg (Germany)
22 presentations
1 follower

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

This platform is supported by

logo Novo Nordisk